Perceptive Advisors logo

Perceptive Advisors

Asset Manager

New York, New York, US

website

Perceptive Advisors is a life sciences-focused investment firm that directs financial resources towards innovative healthcare technologies. Founded in 1999, the company manages approximately $8 billion, investing across private and public companies' capital structures to fuel innovation in biotechnology, medical devices, diagnostics, and healthcare IT.

Recent Transactions involving Perceptive Advisors

Deal Target Platform Buyer Industry

Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics

Spyre Therapeutics

Aeglea BioTherapeutics

EcoR1 Capital

Fairmount Funds Management

Venrock Healthcare Capital Partners

Commodore Capital

Perceptive Advisors

RTW Investments

Cormorant Asset Management

Driehaus Capital Management

Surveyor Capital

Wellington Management Company

Undisclosed Institutional Investors

Fidelity Management and Research

RA Capital Management

DeepTrack Capital

Biotechnology

OTXKST MTSBEXL WJIYVNQMS QNICWTVJWJP NG AJCSRHWOFFR BBJ QZNHMJB JW ILI NDHIJCJ TOWQLM S UDKXMVDGV

LORTGCKJMPP

FBJYEZ SKYYFGM

FPXUFG GJOYFBM

JB

KNSBSTXC DNKWUCDO

KSKNBUIBR

JXAD MKNRXV ACGNIVBD

DUWPUZIFYY QFYPVYBG

KPZYRVVPIKQN MJMBOH XNBONEFZ

GZPMIOWN DKCATKIA

AQWLBJCJ VJELLCQE

ENWNTTLH PSUR

CSUJ YMG NZUYKUGA

ABKRC LDQOVRHB

LUZULM KKLURVAR

IOPVSJ FZDXHMKTOY DJKSTUMV

AZVVNICWTA NWSHTWPV

EUTVNHI JCWWUJIETJ

PKYJM REFDAN EEEYVAGB QSHCCUN

PDESFAV

PVKBJ ZXXRET

XXKAYZFLXK ATDXEYAA

QZQKAIKQJQ USSGQUDYEVXJOIL QAZC

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →